Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06311955 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor

StatusRecruiting
PhasePhase 2
SponsorJian Chen
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Apr 1, 2024 to Jul 1, 2025v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Jian Chen
5 trials monitored
See all monitored trials
To observe the efficacy and toxicities of heavy ion radiation therapy for locally advanced or advanced primary thymic epithelial malignant tumor received R2 resection. The primary endpoint was progression-free survival and toxicities, and the secondary endpoint was local relapse-free survival, overall survival and cause-specific survival.
Trial Details
NCT Number NCT06311955
Lead Sponsor Jian Chen
Conditions
(from sponsor)		 Thymic Epithelial Tumor, Radiotherapy Side Effect, Carbon Ion Radiotheray, Heavy Ion Radiotherapy
Related terms Radiation Injuries, Thymic epithelial tumor
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov